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LETTERS TO THE EDITOR
Comments on the Fluorescein Excitation and Emission Polarization
Spectra in Living Cells
Dear Sir:
We are very perplexed by a recent paper of Cercek et al. (1) in this journal. They report results of
fluorescence polarization studies in mammalian cells that apparently resolve a disagreement between
their work and that of Lindmo and Steen (2). However, their results also indicate that it should be
impossible for us to make measurements that we have now been making routinely for more than three
years.
In several instances, biologically significant changes in the state of a living cell have been detected by
measuring changes in the polarization of fluorescence from fluorescein molecules located in the
cytoplasm of the cell. However, not all investigators have been successful in demonstrating the
phenomenon. Thus, Lindmo and Steen (2), in a study of cultured NHIK 3025 cells, found no difference
in polarization values for cells in S and GI phases of the cell cycle, whereas previously Cercek et al. (3),
in a study of cultured CHO cells, found a large difference. There are many possible reasons for this
disagreement. To name a few: (a) Different cell lines were used. (b) There are small differences in the
labeling procedures used. (c) The methods used for measuring polarization were very different. Thus,
Cercek et al. (3) made their measurements on a bulk suspension of cells, a procedure that requires
careful calibration and correction for leakage of fluorescein molecules from the cells into the supporting
fluid, whereas Lindmo and Steen made their measurements on individual cells in a flow cytometer, a
procedure in which calibration and background correction requirements are much less demanding.
In a recent paper in this journal (I), Cercek et al. offer an explanation different from any of the above
for the disagreement. They claim that the polarization measured for fluorescein molecules in the
cytoplasm of a mammalian cell is a strong function of both the wavelengths used to excite and to
measure the fluorescence. In particular, they present data showing that polarization shifts are minimal
unless the excitation wavelength is near 470 nm and the emission wavelength near 510 nm, and are
nonexistent for an excitation wavelength of 488 nm (as used by Lindmo and Steen). They show this
wavelength dependence in cell cycle studies of cultured S3 fibroblasts and also in studies of the response
of human lymphocytes to phytohemagglutinin (PHA), a system which they have previously shown (4)
also shows polarization shifts shortly after PHA addition.
We are making extensive studies of shifts in polarization after biological activation in several
biological systems, including the response of human lymphocytes to PHA. These measurements are
being made in a flow cytometer-cell sorter system basically similar to that of Lindmo and Steen, and we
have used an excitation wavelength of 488 nm from an argon ion laser as described in detail else-
where (5). Filters are used to exclude the scattered laser light and long wavelength light, also as
described elsewhere (6). Fig. I shows the wavelength distribution of the fluroescence spectrum actually
analyzed. It is centered in a broad band around 540 nm and almost entirely excludes 510 nm.
We are presently in the middle of a double-blind study to determine whether we can confirm and
extend the results of Cercek and Cercek (7) that fluorescence polarization measurements can distinguish
women with early recurrent breast cancer, not evident by simple clinical investigation, from normal
individuals. Some of the controls for this study are shown in Fig. 2. Each point represents the
polarization values (P) measured for the peripheral blood lymphocytes from a single individual within
1 h after exposure to 2% PHA. Clearly, for normal individuals, P has decreased on exposure to PHA.
The values obtained for P in the absence of PHA and the average downshift obtained on adding PHA
(4.8%) are in general agreement with the results of Cercek and Cercek (4). However, for patients with
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FIGURE 1 Wavelength cistribution of fluorescence spectrum: (a) fluorescence intensity spectrum of
fluorescein isothiocyanate (FITC) in aqueous solution, arbitrary scale with maximum of 100; (b)
measured filter transmission, percent; (c) fluorescence transmitted through the filter stack, same scale as
a. For details, see reference 6.
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FIGURE 2 Polarization values for individual peripheral blood lymphocyte samples from either normals
(-) or patients with recurrent breast cancer before treatment (A) measured with or without prior exposure
to PHA. See text.
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recurrent breast cancer before any treatment, P values have changed little, if at all, in response to PHA
addition. The difference between the two groups is statistically significant (p << 0.005) as judged by
the Wilcoxon rank sum test. We have recently made a few polarization measurements using an argon
ion laser line at 472.8 nm and get results qualitatively similar to those of Fig. 2 which we obtained with
measurements at 488 nm.
We can find no ready explanation for our disagreement with Cercek et al. (1), i.e., that we are
observing shifts in polarization similar to those they observe but at an emission and excitation
wavelength for which they observe no effect. However, there are two major differences in procedure
which may ultimately lead to an explanation. First, their measurements are made on a carefully selected
subpopulation of lymphocytes (1), whereas our measurements are made on all lymphocytes: All cells in
the peripheral blood buffy coat are run through the flow cytometer, and the scatter signal is used to
distinguish lymphocytes from other cells (8). Second, their measurements must be made within minutes
of introducing fluorescein inside the cells (1), whereas our measurements are made at least 20 min after
fluorescein introduction (8). It is possible that we are looking at different phenemona.
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